Desmopressin Impurity 14 is a related peptide species that forms during synthesis or degradation of desmopressin. Subtle sequence or protecting-group differences shift its chromatographic and spectrometric signatures. Researchers use it to validate analytical sensitivity and specificity. Applications include impurity profiling, peptide-process characterization, and structural-variant comparison.
CAT No: Z10-101-193
Desmopressin impurity 14, a structurally related analog of desmopressin, serves as a crucial reference compound in pharmaceutical research and development. As an identified process-related impurity, its presence is often monitored during the synthesis and quality control of desmopressin, a widely studied synthetic peptide. The unique molecular structure of Desmopressin impurity 14 allows researchers to investigate the specificity of analytical detection methods and to ensure the robustness of synthetic pathways. By providing a reliable standard for impurity profiling, it plays a pivotal role in the evaluation of peptide manufacturing processes and the overall assessment of product consistency. Its scientific value is underscored by its frequent use in advanced analytical, stability, and degradation studies, contributing to the comprehensive understanding of desmopressin and its related substances.
Analytical Method Development: Desmopressin impurity 14 is extensively utilized in the development and validation of chromatographic and spectrometric methods. Researchers employ this impurity to challenge the selectivity and sensitivity of techniques such as HPLC and LC-MS, ensuring that these analytical methods can accurately distinguish between the main active pharmaceutical ingredient and structurally similar impurities. By incorporating impurity 14 as a standard, laboratories can optimize detection parameters, reduce the risk of co-elution, and enhance the reliability of quantitative assessments during routine quality control.
Impurity Profiling and Characterization: In the context of impurity profiling, Desmopressin impurity 14 is instrumental in identifying and quantifying related substances that may arise during peptide synthesis or storage. Its well-characterized structure enables precise assignment in impurity maps, facilitating the elucidation of degradation pathways and the assessment of process reproducibility. The use of this impurity as a reference supports comprehensive impurity characterization studies, allowing for a deeper understanding of chemical stability and the identification of potential challenges in formulation or storage.
Peptide Synthesis Optimization: Researchers investigating synthetic routes for desmopressin often utilize impurity 14 to assess the efficiency and selectivity of various reaction conditions. By monitoring the formation and minimization of this specific impurity, chemists can refine purification strategies, adjust reagent concentrations, and modify reaction parameters to improve overall yield and product purity. This targeted approach to process optimization not only enhances manufacturing efficiency but also contributes to the development of more sustainable and reproducible synthetic methodologies.
Degradation and Stability Studies: The presence of Desmopressin impurity 14 is particularly valuable in forced degradation and stability studies. Scientists introduce this impurity into formulations or bulk substances to simulate potential degradation scenarios, enabling the evaluation of product robustness under stress conditions such as heat, light, or humidity. By tracking changes in impurity levels over time, researchers gain insight into the stability profile of desmopressin, informing decisions on packaging, storage, and handling requirements for both research and industrial applications.
Reference Standard for Quality Control: In quality control laboratories, Desmopressin impurity 14 is routinely used as a reference standard to verify the accuracy and precision of analytical results. Its inclusion in assay validation protocols ensures that impurity detection remains consistent across different batches and testing environments. By benchmarking analytical systems against this impurity, laboratories can uphold stringent quality assurance practices, ultimately supporting the integrity and reproducibility of pharmaceutical research and development processes. Through these diverse application directions, Desmopressin impurity 14 demonstrates its indispensable role in advancing the scientific understanding and technical mastery of peptide-based compounds.
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
2. Cationic cell-penetrating peptides are potent furin inhibitors
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More